Nifty
Sensex
:
:
24457.15
80845.75
181.10 (0.75%)
597.67 (0.74%)

Hospital & Healthcare Services

Rating :
N/A

BSE: 543328 | NSE: KRSNAA

996.90
03-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1008.90
  •  1029.90
  •  993.00
  •  998.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  137440
  •  1383.65
  •  1044.00
  •  528.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,225.26
  • 46.60
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,331.61
  • 0.25%
  • 3.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.17%
  • 21.05%
  • 28.41%
  • FII
  • DII
  • Others
  • 3.63%
  • 14.42%
  • 5.32%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 17.95
  • 10.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 1.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -5.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
17.9
26.3
41.05
52.58
P/E Ratio
56.44
38.41
24.61
19.22
Revenue
620
794
1074
1252
EBITDA
144
205
280
329
Net Income
57
84
133
168
ROA
5.5
7.7
11.1
12.2
P/Bk Ratio
4.03
3.63
3.17
2.73
ROE
7.34
9.75
12.8
14.98
FCFF
-171.57
-16.8
33.6
107.1
FCFF Yield
-5.15
-0.5
1.01
3.22

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
186.34
155.45
19.87%
170.23
139.58
21.96%
166.28
133.23
24.81%
158.32
118.10
34.06%
Expenses
136.94
123.66
10.74%
127.56
108.21
17.88%
122.58
98.74
24.14%
120.93
88.69
36.35%
EBITDA
49.40
31.79
55.39%
42.67
31.36
36.07%
43.70
34.48
26.74%
37.39
29.41
27.13%
EBIDTM
26.51%
20.45%
25.06%
22.47%
26.28%
25.88%
23.62%
24.90%
Other Income
4.59
4.16
10.34%
7.32
4.22
73.46%
4.34
5.93
-26.81%
4.08
4.54
-10.13%
Interest
6.39
3.06
108.82%
5.32
1.96
171.43%
7.32
2.24
226.79%
4.15
2.26
83.63%
Depreciation
22.20
19.46
14.08%
21.47
15.73
36.49%
18.12
14.60
24.11%
21.23
13.91
52.62%
PBT
25.40
13.42
89.27%
23.20
17.89
29.68%
22.61
23.58
-4.11%
16.09
17.78
-9.51%
Tax
5.81
2.92
98.97%
5.28
3.25
62.46%
3.88
4.66
-16.74%
3.12
4.14
-24.64%
PAT
19.60
10.50
86.67%
17.92
14.64
22.40%
18.73
18.92
-1.00%
12.97
13.64
-4.91%
PATM
10.52%
6.75%
10.53%
10.49%
11.26%
14.20%
8.19%
11.55%
EPS
6.07
3.34
81.74%
5.55
4.66
19.10%
5.80
6.03
-3.81%
4.02
4.34
-7.37%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Net Sales
681.17
619.63
487.12
455.45
Net Sales Growth
24.67%
27.20%
6.95%
 
Cost Of Goods Sold
165.16
141.04
74.18
60.30
Gross Profit
516.01
478.59
412.94
395.15
GP Margin
75.75%
77.24%
84.77%
86.76%
Total Expenditure
508.01
475.39
364.82
323.97
Power & Fuel Cost
-
12.17
9.08
6.34
% Of Sales
-
1.96%
1.86%
1.39%
Employee Cost
-
111.47
74.56
54.15
% Of Sales
-
17.99%
15.31%
11.89%
Manufacturing Exp.
-
77.98
99.16
128.38
% Of Sales
-
12.58%
20.36%
28.19%
General & Admin Exp.
-
129.78
105.63
72.08
% Of Sales
-
20.94%
21.68%
15.83%
Selling & Distn. Exp.
-
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
Miscellaneous Exp.
-
2.95
2.21
2.73
% Of Sales
-
0.48%
0.45%
0.60%
EBITDA
173.16
144.24
122.30
131.48
EBITDA Margin
25.42%
23.28%
25.11%
28.87%
Other Income
20.33
16.80
19.38
14.91
Interest
23.18
16.49
7.70
18.49
Depreciation
83.02
74.55
53.78
41.39
PBT
87.30
70.01
80.20
86.51
Tax
18.09
13.17
18.09
18.12
Tax Rate
20.72%
18.81%
22.56%
20.95%
PAT
69.22
56.84
62.11
68.39
PAT before Minority Interest
69.22
56.84
62.11
68.39
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
10.16%
9.17%
12.75%
15.02%
PAT Growth
19.97%
-8.48%
-9.18%
 
EPS
21.43
17.60
19.23
21.17

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Shareholder's Funds
809.80
738.74
684.41
Share Capital
16.14
15.70
15.70
Total Reserves
791.26
720.37
666.67
Non-Current Liabilities
79.01
70.58
69.94
Secured Loans
41.88
24.28
33.07
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
1.77
1.23
0.32
Current Liabilities
281.47
99.19
121.02
Trade Payables
82.32
62.13
77.30
Other Current Liabilities
99.20
34.92
41.74
Short Term Borrowings
95.72
0.00
0.00
Short Term Provisions
4.23
2.15
1.98
Total Liabilities
1,170.28
908.51
875.37
Net Block
647.15
470.68
385.69
Gross Block
873.64
626.62
491.35
Accumulated Depreciation
226.49
155.94
105.66
Non Current Assets
749.10
685.59
541.22
Capital Work in Progress
9.85
25.48
28.26
Non Current Investment
0.29
0.29
0.29
Long Term Loans & Adv.
62.38
26.39
17.87
Other Non Current Assets
29.43
162.75
109.11
Current Assets
421.19
222.92
334.15
Current Investments
0.00
0.00
0.00
Inventories
35.81
25.07
9.17
Sundry Debtors
176.29
73.10
57.87
Cash & Bank
53.55
108.80
241.88
Other Current Assets
155.54
10.10
8.17
Short Term Loans & Adv.
131.93
5.85
17.05
Net Current Assets
139.72
123.72
213.13
Total Assets
1,170.29
908.51
875.37

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
24.34
76.30
128.42
PBT
70.01
80.20
86.51
Adjustment
69.92
44.81
49.20
Changes in Working Capital
-96.78
-35.58
-0.66
Cash after chg. in Working capital
43.15
89.43
135.05
Interest Paid
0.00
0.00
0.00
Tax Paid
-18.80
-13.13
-6.63
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-128.88
-108.89
-240.64
Net Fixed Assets
-231.39
-132.49
Net Investments
0.00
0.00
Others
102.51
23.60
Cash from Financing Activity
84.19
-33.15
175.99
Net Cash Inflow / Outflow
-20.34
-65.73
63.78
Opening Cash & Equivalents
22.72
88.45
24.68
Closing Cash & Equivalent
2.38
22.72
88.45

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
250.05
234.43
217.33
ROA
5.47%
6.96%
7.81%
ROE
7.36%
8.76%
10.02%
ROCE
9.94%
11.75%
14.47%
Fixed Asset Turnover
0.83
0.87
0.93
Receivable days
73.45
49.07
46.38
Inventory Days
17.93
12.83
7.35
Payable days
186.90
343.02
467.93
Cash Conversion Cycle
-95.52
-281.13
-414.20
Total Debt/Equity
0.20
0.04
0.06
Interest Cover
5.25
11.42
5.68

News Update:


  • Krsnaa Diagnostics - Quarterly Results
    25th Oct 2024, 20:29 PM

    Read More
  • Krsnaa Diagnostics to expand Radiology services, Pathology laboratory services in Ranchi
    11th Oct 2024, 10:22 AM

    The company has received the signed agreement from the Medical Superintendent, Sadar Hospital, Ranchi, Jharkhand

    Read More
  • Krsnaa Diagnostics enters into strategic partnership with Medikabazaar
    1st Oct 2024, 14:40 PM

    The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance

    Read More
  • Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare
    26th Sep 2024, 16:51 PM

    Krsnaa will deliver a comprehensive suite of integrated diagnostic services at Apulki’s facilities, enhancing access to advanced and super specialized diagnostics

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.